Drug Profile
HIV vaccine - Epimmune
Alternative Names: CY 2301; HIV vaccine - CytelLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Epimmune
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 15 Jul 1999 Epimmune has been awarded a US patent covering its epitope-based vaccine technology
- 31 Dec 1997 Discontinued - Phase-II for HIV infections treatment in USA (unspecified route)
- 28 Aug 1997 Phase-II clinical trials for HIV infections treatment in USA (Unknown route)